Detalhe da pesquisa
1.
The phase I/II eNRGy trial: Zenocutuzumab in patients with cancers harboring NRG1 gene fusions.
Future Oncol
; 2024 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38348690
2.
Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis.
Int J Mol Sci
; 25(7)2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38612799
3.
[Criteria for inpatient diagnostic and treatment of patients with lung cancer, mesothelioma or thymoma]. / Erratum: Kriterien für die Behandlung von thoraxonkologischen Erkrankungen als stationäre Leistung bei Erwachsenen.
Pneumologie
; 78(4): e1, 2024 Apr.
Artigo
em Alemão
| MEDLINE | ID: mdl-38608660
4.
[Criteria for inpatient diagnostic and treatment of patients with lung cancer, mesothelioma or thymoma]. / Kriterien für die Behandlung von thoraxonkologischen Erkrankungen als stationäre Leistung bei Erwachsenen.
Pneumologie
; 78(4): 233-235, 2024 Apr.
Artigo
em Alemão
| MEDLINE | ID: mdl-38608657
5.
Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315).
JTO Clin Res Rep
; 5(4): 100626, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38586301
6.
Outcome of First-Line Treatment With Pembrolizumab According to KRAS/TP53 Mutational Status for Nonsquamous Programmed Death-Ligand 1-High (≥50%) NSCLC in the German National Network Genomic Medicine Lung Cancer.
J Thorac Oncol
; 19(5): 803-817, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38096950
7.
Is Dementia Associated with COVID-19 Mortality? A Multicenter Retrospective Cohort Study Conducted in 50 Hospitals in Germany.
J Alzheimers Dis
; 91(2): 719-726, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36463455
8.
High In-Hospital Mortality in SARS-CoV-2-Infected Patients with Active Cancer Disease during Omicron Phase of the Pandemic: Insights from the CORONA Germany Study.
Oncol Res Treat
; 46(5): 201-210, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36822167
9.
NSCLC with uncommon EGFR mutations treated with atezolizumab plus bevacizumab and chemotherapy.
Lung Cancer
; 174: 141-145, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36402005
10.
The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions.
Eur J Cancer
; 170: 106-118, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35598358
11.
Efficacy of docetaxel plus ramucirumab as palliative second-line therapy following first-line chemotherapy plus immune-checkpoint-inhibitor combination treatment in patients with non-small cell lung cancer (NSCLC) UICC stage IV.
Transl Lung Cancer Res
; 10(7): 3093-3105, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34430350
12.
Clinical outcome, risk assessment, and seasonal variation in hospitalized COVID-19 patients-Results from the CORONA Germany study.
PLoS One
; 16(6): e0252867, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34138888
13.
Prognostic Impact of Acute Cardiovascular Events in COVID-19 Hospitalized Patients-Results from the CORONA Germany Study.
J Clin Med
; 10(17)2021 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34501427
14.
Efficacy of Docetaxel Plus Ramucirumab as Palliative Third-Line Therapy Following Second-Line Immune-Checkpoint-Inhibitor Treatment in Patients With Non-Small-Cell Lung Cancer Stage IV.
Clin Med Insights Oncol
; 14: 1179554920951358, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32884390
15.
Integration of Tumor Mutation Burden and PD-L1 Testing in Routine Laboratory Diagnostics in Non-Small Cell Lung Cancer.
Cancers (Basel)
; 12(6)2020 Jun 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32599951
16.
A Randomized Phase III Study of Abemaciclib Versus Erlotinib in Patients with Stage IV Non-small Cell Lung Cancer With a Detectable KRAS Mutation Who Failed Prior Platinum-Based Therapy: JUNIPER.
Front Oncol
; 10: 578756, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33194700